Agreement duration: The UNSW agreement is from 1st January 2023 - 31st December 2023. An agreement was also in place from January 1st 2022 - December 31st 2022.
Summary: Future Science focusses on publishing research in areas of biotechnology and medicine, as well as topics in biological, life and physical sciences that are of relevance to human health.
Agreement details: Future Science Group - ESAC Initiative
Titles included: The 19 hybrid journals included in the agreement can be found on the Future Medicine and Future Science websites. The agreement does not include the Future Science Group Gold OA journals. Further, drug evaluation articles and content or research that is sponsored or funded by pharmaceutical or biotechnology companies is excluded from this agreement.
Information for authors: UNSW corresponding authors must use their UNSW institutional email address (email@example.com) to be eligible under this agreement.
Acceptance date: Eligible articles that have an acceptance date during the term of this agreement are eligible to be published open access under the terms of the agreement.
Number of included articles: There is no limit on the number of articles that can be published by UNSW corresponding authors under the agreement.
Sharing via repositories: This agreement aligns with UNSW's Open Access policy however, there is no automated loading to UNSWorks. Papers are deposited directly to PubMed.
How to submit your article for open access publishing:
Corresponding authors should not use personal email addresses (e.g. Hotmail, Gmail) or email addresses affiliated with other organisations, research centres or institutes. Otherwise they may be ineligible under the terms of this agreement.
For any queries about this transformative agreement please contact the Collection Development & Policy Unit via firstname.lastname@example.org